Peptide & GLP-1 compounding status tracker
Where the FDA and the states stand on compounding the peptides and GLP-1s med spas ask about — 503A bulks-list status, PCAC reviews, and state overlays. Every asserted status links to the government document it came from.
We do not sell, source, or supply any substance. This is a monitoring record compiled from public government sources (the Federal Register, FDA, PCAC, and state authorities) — assembled so you can find the primary document, not a product to buy.
Next FDA review
- Oct 25, 2024 — Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List source ↗
- Apr 16, 2026 — Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List source ↗
- Apr 16, 2026 — Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List source ↗
- Apr 16, 2026 — Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List source ↗
| Substance | Class | Current federal standing | Last change | Source |
|---|---|---|---|---|
| Liraglutide | GLP-1 | Federal action on record | Jun 26, 2026 | doc ↗ |
| Semaglutide | GLP-1 | Federal action on record | Jun 26, 2026 | doc ↗ |
| Tirzepatide | GLP-1 | Federal action on record | Jun 26, 2026 | doc ↗ |
| BPC-157 | Peptide | Under PCAC review | Apr 16, 2026 | doc ↗ |
| CJC-1295 | Peptide | Under PCAC review | Oct 25, 2024 | doc ↗ |
| Dihexa | Peptide | Monitoring — no published change yet | — | — |
| Emideltide | Peptide | Under PCAC review | Apr 16, 2026 | doc ↗ |
| Epitalon | Peptide | Under PCAC review | Apr 16, 2026 | doc ↗ |
| GHK-CuCopper tripeptide-1 | Peptide | Monitoring — no published change yet | — | — |
| KPV | Peptide | Under PCAC review | Apr 16, 2026 | doc ↗ |
| LL-37Cathelicidin | Peptide | Monitoring — no published change yet | — | — |
| Melanotan II | Peptide | Monitoring — no published change yet | — | — |
| MOTS-c | Peptide | Under PCAC review | Apr 16, 2026 | doc ↗ |
| PEG-MGF | Peptide | Monitoring — no published change yet | — | — |
| Semax | Peptide | Under PCAC review | Apr 16, 2026 | doc ↗ |
| TB-500Thymosin beta-4 | Peptide | Under PCAC review | Apr 16, 2026 | doc ↗ |
| BotoxonabotulinumtoxinA | Neurotoxin | Monitoring — no published change yet | — | — |
Get the change the moment it lands
The free weekly Brief flags FDA and state moves on peptide & GLP-1 compounding — with the source and the date. Members get real-time alerts for their states.
Get the free Brief →Informational monitoring compiled from public government sources — not legal or medical advice. No efficacy claims. Verify against the primary source and your own counsel before acting.